Classification of gastro-entero-pancreatic neuroendocrine tumors

被引:0
|
作者
Perren, A. [1 ]
Schmitt, A. [2 ]
Komminoth, P. [3 ]
Pavel, M. [4 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Inst Pathol & Patholog Anat, D-81675 Munich, Germany
[2] Univ Spital Zurich, Dept Pathol, Inst Klin Pathol, Zurich, Switzerland
[3] Stadtspital Triemli, Inst Pathol, Zurich, Switzerland
[4] Univ Med Berlin, Charite, Med Klin Schwerpunkt Hepatol & Gastroenterol, Berlin, Germany
来源
RADIOLOGE | 2009年 / 49卷 / 03期
关键词
Neuroendocrine tumors; Nomenclature; TNM staging; WHO classification; CARCINOID-TUMORS; ENDOCRINE-TUMORS; GRADING SYSTEM; PANCREAS; GASTRINOMAS; MANAGEMENT; FEATURES; RECTUM; COLON; ILEUM;
D O I
10.1007/s00117-008-1781-z
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Tumors of the disseminated/diffuse neuroendocrine system (NET) are characterized by a common phenotype. However, the biology varies according to histomorphology, endocrine symptoms and organ of origin. The WHO classification takes these differences into account and uses a common framework, where the parameters size and extent of invasion vary according to the organ of origin. In order to achieve a further standardization of reporting the European Neuroendocrine Tumor Society (ENETS) recently proposed a tumor-node-metastasis (TNM) staging and grading system for gastro-entero-pancreatic NET.
引用
收藏
页码:198 / 205
页数:8
相关论文
共 50 条
  • [21] Imaging-guided precision medicine in non-resectable gastro-entero-pancreatic neuroendocrine tumors: A step-by-step approach
    Rozenblum, Laura
    Mokrane, Fatima-Zohra
    Yeh, Randy
    Sinigaglia, Mathieu
    Besson, Florent L.
    Seban, Romain-David
    Zadro, Charline
    Dierickx, Lawrence
    Chougnet, Cecile N.
    Partouche, Ephraim
    Revel-Mouroz, Paul
    Zhao, Binsheng
    Otal, Philippe
    Schwartz, Lawrence H.
    Dercle, Laurent
    EUROPEAN JOURNAL OF RADIOLOGY, 2020, 122
  • [22] The antiproliferative effect of somatostatin analogs : clinical relevance in patients with neuroendocrine gastro-entero-pancreatic tumours
    Verslype, C.
    Carton, S.
    Borbath, I.
    Delaunoit, T.
    Demetter, P.
    Demolin, G.
    Hendlisz, A.
    Pattyn, P.
    Pauwels, S.
    Peeters, M.
    Roeyen, G.
    Van Hootegem, Ph.
    Van Laethem, J. L.
    Van Cutsem, E.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2009, 72 (01) : 54 - 58
  • [23] Well-differentiated gastro-entero-pancreatic neuroendocrine tumors with positive FDG-PET/CT: a retrospective chart review
    Haidar, Mohamad
    Al Mahmasani, Layal
    Chehade, Laudy
    Elias, Charbel
    El Jebai, Malak
    Temraz, Sally
    Charafeddine, Maya
    Al Darazi, Monita
    Shamseddine, Ali
    NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (06) : 471 - 479
  • [24] Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome
    Panzuto, Francesco
    Merola, Elettra
    Pavel, Marianne Ellen
    Rinke, Anja
    Kump, Patrizia
    Partelli, Stefano
    Rinzivillo, Maria
    Rodriguez-Laval, Victor
    Pape, Ulrich Frank
    Lipp, Rainer
    Gress, Thomas
    Wiedenmann, Bertram
    Falconi, Massimo
    Delle Fave, Gianfranco
    ONCOLOGIST, 2017, 22 (04): : 409 - 415
  • [25] Role of [F-18]FDG PET/CT in the management of G1 gastro-entero-pancreatic neuroendocrine tumors
    Magi, Ludovica
    Prosperi, Daniela
    Lamberti, Giuseppe
    Marasco, Matteo
    Ambrosini, Valentina
    Rinzivillo, Maria
    Campana, Davide
    Gentiloni, Guido
    Annibale, Bruno
    Signore, Alberto
    Panzuto, Francesco
    ENDOCRINE, 2022, 76 (02) : 484 - 490
  • [26] Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Oberg, K.
    Knigge, U.
    Kwekkeboom, D.
    Perren, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 124 - 130
  • [27] Impact of VEGF and VEGFR Polymorphisms on Neuroendocrine Tumors of the Gastro-Entero-Pancreatic System (GEP-NET) Outcome
    Berardi, R.
    Pagliaretta, S.
    Rinaldi, S.
    Morgese, F.
    Partelli, S.
    Caramanti, M.
    Onofri, A.
    Polenta, V.
    Pasquini, S.
    Falconi, M.
    Cascinu, S.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 105 - 105
  • [28] Nuclear medicine imaging of gastro-entero-pancreatic neuroendocrine tumors. The key role of cellular differentiation and tumor grade: from theory to clinical practice
    Rust, Edmond
    Hubele, Fabrice
    Marzano, Ettore
    Goichot, Bernard
    Pessaux, Patrick
    Kurtz, Jean-Emmanuel
    Imperiale, Alessio
    CANCER IMAGING, 2012, 12 (01): : 173 - 184
  • [29] Frequency and characterization of gastro-entero-pancreatic neuroendocrine tumor patients with high-grade of uptake at somatostatin receptor scintigraphy
    Chougnet, Cecile N.
    Leboulleux, Sophie
    Caramella, Caroline
    Lumbroso, Jean
    Borget, Isabelle
    Deandreis, Desiree
    Duvillard, Pierre
    Elias, Dominique
    de Baere, Thierry
    Velayoudom-Cephise, Fritz-Line
    Guigay, Joel
    Ducreux, Michel
    Schlumberger, Martin
    Baudin, Eric
    ENDOCRINE-RELATED CANCER, 2013, 20 (02) : 229 - 239
  • [30] Radiological Imaging of Gastro-Entero-Pancreatic Neuroendocrine Tumors. The Review of Current Literature Emphasizing the Diagnostic Value of Chosen Imaging Methods
    Poltorak-Szymczak, Gabriela
    Budlewski, Tadeusz
    Furmanek, Mariusz Ireneusz
    Wierzba, Waldemar
    Sklinda, Katarzyna
    Walecki, Jerzy
    Mruk, Bartosz
    FRONTIERS IN ONCOLOGY, 2021, 11